Resected pancreatic ductal adenocarcinomas with recurrence limited in lung have a significantly better prognosis than those with other recurrence patterns

This publication has 11 references indexed in Scilit:

• Recent progress in pancreatic cancer
  CA: A Cancer Journal for Clinicians, 2013
• Pulmonary Resection for Isolated Pancreatic Adenocarcinoma Metastasis: an Analysis of Outcomes and Survival
  Journal of Gastrointestinal Surgery, 2011
• The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis: Emphasis on Non-small Cell Lung Cancer
  Journal of Thoracic Oncology, 2011
• Results and patterns of failure in patients treated with adjuvant combined chemoradiation therapy for resected pancreatic adenocarcinoma
  Cancer, 2009
• Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma
  European Journal of Surgical Oncology, 2009
• Analysis of Fluorouracil-Based Adjuvant Chemotherapy and Radiation After Pancreaticoduodenectomy for Ductal Adenocarcinoma of the Pancreas: Results of a Large, Prospectively Collected Database at the Johns Hopkins Hospital
  Journal of Clinical Oncology, 2008
• Patterns of Recurrence After Curative Resection of Pancreatic Cancer, Based on Autopsy Findings
  Journal of Gastrointestinal Surgery, 2006
• Prognostic factors in resected pancreatic adenocarcinoma: Analysis of actual 5-year survivors1
  Journal of the American College of Surgeons, 2004
• Resected adenocarcinoma of the pancreas—616 patients: results, outcomes, and prognostic indicators
  Journal of Gastrointestinal Surgery, 2000
• Recurrence after resection for ductal adenocarcinoma of the pancreas
  World Journal of Surgery, 1997